Discovery and validation of a novel blood‐based molecular biomarker of rejection following liver transplantation

Noninvasive biomarker profiles of acute rejection (AR) could affect the management of liver transplant (LT) recipients. Peripheral blood was collected following LT for discovery (Northwestern University [NU]) and validation (National Institute of Allergy and Infectious Diseases Clinical Trials in Or...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Transplant
Auteurs principaux: Levitsky, Josh, Asrani, Sumeet K., Schiano, Thomas, Moss, Adyr, Chavin, Kenneth, Miller, Charles, Guo, Kexin, Zhao, Lihui, Kandpal, Manoj, Bridges, Nancy, Brown, Merideth, Armstrong, Brian, Kurian, Sunil, Demetris, Anthony J., Abecassis, Michael
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
ORIGINAL ARTICLES
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496674/
https://ncbi.nlm.nih.gov/pubmed/32356368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15953
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires